Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: Implication for preventive therapy

Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease

Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma

Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation

CMV Infection after Transplant from Cord Blood Compared to Other Alternative Donors: The Importance of Donor-Negative CMV Serostatus

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NKG2A and LIR-1 Blockade

Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease

Update on graft versus host disease.

Hematopoietic stem cell transplantation for RelB deficiency

T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease

Vaccination of Children following Allogeneic Stem Cell Transplantation

Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Costs and Cost-Effectiveness of Allogeneic Stem Cell Transplantation in Children Are Predictable